Immune evasion in primary testicular and central nervous system lymphomas: HLA loss rather than 9p24.1/PD-L1/PD-L2 alterations

Marthe Minderman; Avital Amir; Willem Kraan; Esther J. M. Schilder-Tol; Monique E. C. M. Oud; Cornelis G. Scheepstra; Arnold L. Noorduyn; Philip M. Kluin; Marie Jose Kersten; Marcel Spaargaren; Steven T. Pals

doi:10.1182/blood.2021011366

Immune evasion in primary testicular and central nervous system lymphomas: HLA loss rather than 9p24.1/PD-L1/PD-L2 alterations

Marthe Minderman, Avital Amir, Willem Kraan, Esther J. M. Schilder-Tol, Monique E. C. M. Oud, Cornelis G. Scheepstra, Arnold L. Noorduyn, Philip M. Kluin, Marie Jose Kersten, Marcel Spaargaren, Steven T. Pals^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

14 Citations (Scopus)

107 Downloads (Pure)

Original language	English
Pages (from-to)	1194-1197
Number of pages	4
Journal	Blood
Volume	138
Issue number	13
DOIs	https://doi.org/10.1182/blood.2021011366
Publication status	Published - 30-Sept-2021

Keywords

B-CELL LYMPHOMAS
PRIVILEGED SITES
PD-1 BLOCKADE
EXPRESSION
NIVOLUMAB

Access to Document

10.1182/blood.2021011366

Immune evasion in primary testicular and central nervous system lymphomas: HLA loss rather than 9p24.1/PD-L1/PD-L2 alterationsFinal publisher's version, 766 KBLicence: Taverne

Handle.net

Persistent link

Cite this

Minderman, M., Amir, A., Kraan, W., Schilder-Tol, E. J. M., Oud, M. E. C. M., Scheepstra, C. G., Noorduyn, A. L., Kluin, P. M., Kersten, M. J., Spaargaren, M., & Pals, S. T. (2021). Immune evasion in primary testicular and central nervous system lymphomas: HLA loss rather than 9p24.1/PD-L1/PD-L2 alterations. Blood, 138(13), 1194-1197. https://doi.org/10.1182/blood.2021011366

@article{68f658fa02334c6d8e53f6f00d522530,

title = "Immune evasion in primary testicular and central nervous system lymphomas: HLA loss rather than 9p24.1/PD-L1/PD-L2 alterations",

keywords = "B-CELL LYMPHOMAS, PRIVILEGED SITES, PD-1 BLOCKADE, EXPRESSION, NIVOLUMAB",

author = "Marthe Minderman and Avital Amir and Willem Kraan and Schilder-Tol, {Esther J. M.} and Oud, {Monique E. C. M.} and Scheepstra, {Cornelis G.} and Noorduyn, {Arnold L.} and Kluin, {Philip M.} and Kersten, {Marie Jose} and Marcel Spaargaren and Pals, {Steven T.}",

year = "2021",

month = sep,

day = "30",

doi = "10.1182/blood.2021011366",

language = "English",

volume = "138",

pages = "1194--1197",

journal = "Blood",

issn = "0006-4971",

publisher = "AMER SOC HEMATOLOGY",

number = "13",

}

TY - JOUR

T1 - Immune evasion in primary testicular and central nervous system lymphomas

T2 - HLA loss rather than 9p24.1/PD-L1/PD-L2 alterations

AU - Minderman, Marthe

AU - Amir, Avital

AU - Kraan, Willem

AU - Schilder-Tol, Esther J. M.

AU - Oud, Monique E. C. M.

AU - Scheepstra, Cornelis G.

AU - Noorduyn, Arnold L.

AU - Kluin, Philip M.

AU - Kersten, Marie Jose

AU - Spaargaren, Marcel

AU - Pals, Steven T.

PY - 2021/9/30

Y1 - 2021/9/30

KW - B-CELL LYMPHOMAS

KW - PRIVILEGED SITES

KW - PD-1 BLOCKADE

KW - EXPRESSION

KW - NIVOLUMAB

U2 - 10.1182/blood.2021011366

DO - 10.1182/blood.2021011366

M3 - Comment/Letter to the editor

SN - 0006-4971

VL - 138

SP - 1194

EP - 1197

JO - Blood

JF - Blood

IS - 13

ER -